KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Teladoc Health (TDOC) Operating Expenses (2016 - 2026)

Teladoc Health's Operating Expenses history spans 13 years, with the latest figure at $675.6 million for Q1 2026.

  • On a quarterly basis, Operating Expenses fell 9.92% to $675.6 million in Q1 2026 year-over-year; TTM through Mar 2026 was $2.7 billion, a 24.63% decrease, with the full-year FY2025 number at $2.8 billion, down 22.21% from a year prior.
  • Operating Expenses hit $675.6 million in Q1 2026 for Teladoc Health, roughly flat from $678.3 million in the prior quarter.
  • Over the last five years, Operating Expenses for TDOC hit a ceiling of $7.2 billion in Q1 2022 and a floor of $675.6 million in Q1 2026.
  • Historically, Operating Expenses has averaged $1.5 billion across 5 years, with a median of $706.3 million in 2023.
  • Biggest five-year swings in Operating Expenses: soared 1243.86% in 2022 and later crashed 90.24% in 2023.
  • Tracing TDOC's Operating Expenses over 5 years: stood at $4.5 billion in 2022, then plummeted by 84.38% to $695.6 million in 2023, then dropped by 0.99% to $688.7 million in 2024, then fell by 1.52% to $678.3 million in 2025, then decreased by 0.39% to $675.6 million in 2026.
  • Business Quant data shows Operating Expenses for TDOC at $675.6 million in Q1 2026, $678.3 million in Q4 2025, and $678.4 million in Q3 2025.